Cardiovascular Safety of Empagliflozin in Patients with Type 2 Diabetes
Now@NEJM,
You are a primary care provider and you’ve heard about a new class of anti-diabetic drugs called the “flozins,” including…
You are a primary care provider and you’ve heard about a new class of anti-diabetic drugs called the “flozins,” including…
By Karin Katz, MD and Loren Wissner Greene, MD…
Ukidney has just posted a new page on their website. It is a library of high impact nephrology research articles. Other sites…
Interview with Sayeed Ikramuddin, MD, author of Roux-en-Y Gastric Bypass vs Intensive Medical Management for the Control of…